SoluBest's management has made a strategic decision to allow customers to directly experience the Solumer technology, and gain maximum exposure for this platform in as little time as possible. Therefore, we have decided to offer the use of our platform for preclinical formulation of up to 5 compounds Free of Charge for companies signing on before the 15th of February.
We stand behind our technology, and as such we don't expect to lose money on this proposition—We are convinced that once you, our clients, see how easy it is to achieve superior proprietary formulations using our platform, it will make SoluBest's technology your natural choice in the future.
This is a no lose-gain only proposition for participants; with no upfront commitment financial or otherwise, you can receive:
1) effective proprietary formulations for solubility-compromised compounds,
2) which at the very least will constitute a second data set to evaluate internal or other external efforts at no cost, and
3) gain first-hand knowledge about a proprietary formulation platform that will reduce development and scale-up times, accelerating compounds' time to market.
If you're interested, contact us and we'll be more than happy to discuss with you how our platform can benefit your development process.
